TOBRAMYCIN

Generic: TOBRAMYCIN

Lupin PharmaceuticalsManufacturer
RESPIRATORY (INHALATION)Route
TOBRAMYCINActive Substance
2017-03-22Original Approval

TOBRAMYCIN is FDA application ANDA208964, sponsored by LUPIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
823 reports
2
PNEUMONIA
818 reports
3
DRUG INEFFECTIVE
770 reports
4
DYSPNOEA
714 reports
5
ACUTE KIDNEY INJURY
710 reports
6
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS
625 reports
7
DEATH
501 reports
8
CONDITION AGGRAVATED
486 reports
9
COUGH
481 reports
10
INFECTION
474 reports